General Biotechnology

Financial Snapshot For November 2003: Hangin’ In There

A dietary magic bullet? Eat, drink and be merry, for tomorrow you can throw down a Longevinex pill, the new

FDA, Industry Collaborate On Genomics Guide Last month, the FDA issued its long-awaited draft guidelines for pharmacogenomic data submission. Companies

Canola Case Tests GMO Patent The future of genetically modified crops in North America is in the hands of a

Food Biotech Is Risky Business The genetically modified food industry has battled opposition from consumer and environmental groups to get

NBI On Drugs You won’t recognize the Nasdaq Biotechnology Index (NBI) the next time you see it. It’s undergone a

Glowing red GM fish to sell in US A tropical fish that fluoresces bright red is set to become the

Slowdown casts doubt on biotech offerings After a two-year capital drought, seven biotechnology and life sciences companies made initial public

Machine Could Sequence Human Genome in a Year A new gene-reading machine is so much faster than existing technology that

Biotech Raises More Cash in 2003 But Europe Weak The global biotechnology industry raised more money by the end of